Healthcare is undergoing a major transformation as alternate care sites become a preferred setting for a growing number of procedures. From dialysis to cardiac monitoring to orthopedic surgeries, these flexible, less acute settings are offering new advantages for patients, pro...

Artificial intelligence is rapidly reshaping the surgical landscape, promising to enhance decision-making, improve patient outcomes, and optimize operational efficiency. With its recent $180 million Series C funding round, Caresyntax is at the forefront of this transformation,...

The medtech journey is rarely a straight line, and both panelists emphasized the importance of perseverance and patience. Makower reflected on the industry’s unique challenges: Visit Us: https://issuu.com/lsieurope/docs/perseverance_the_key_to_long-term_value_creation

The statistics surrounding maternal health are sobering. Andrew Pieprzyk, Vice President of Strategic Development at Hologic, shared, “Less than half of women in the EU were screened for high blood pressure last year and only 24% for diabetes, 20% for cancer, and 8% for STIs....

Technology transfer is a critical bridge between groundbreaking academic research and real-world medtech solutions. Yet, ensuring a smooth transition from lab to market comes with its own set of challenges. At LSI Europe ’24, a panel of seasoned investors and industry leaders...

One of the core themes of the panel was the potential of innovative technologies to mitigate maternal healthcare disparities. The speakers emphasized that solutions must be both preventative and empowering, giving women the tools to actively engage in their healthcare journey....

Moon Surgical has announced that its Maestro System has received FDA clearance for commercial use. This milestone marks a significant leap forward in Moon’s ascent in robot-assisted laparoscopic surgery, promising to enhance the precision and efficiency of various surgical pro...

Cohen's career trajectory is a testament to the power of cross-industry pollination. With nearly three decades in the tech sector, including pivotal roles at IBM and Cisco, he brings a unique perspective to the medtech landscape. Reflecting on his experience, Cohen stated, "It...

Medtech innovation often faces a paradox: balancing the need for groundbreaking technologies with the constraints of efficiency and profitability. This challenge was the focal point of Duke Rohlen’s keynote, The Middle Path to Innovation, presented at LSI Europe ’25. Drawing f...

The healthcare industry is undergoing a seismic shift driven by data-driven business models. This was the central theme of the panel discussion titled “Data-Driven Business Models for Medical Device Innovators: Future or Pipe Dream?” at LSI Europe ’23, moderated by Simon Turne...

The healthcare landscape is evolving rapidly, with digital health platforms reshaping mental and behavioral health and chronic disease management. At LSI Europe ’23, industry leaders explored these opportunities during the panel “Opportunities for Impact: Building & Invest...

At the core of medtech innovation is addressing real clinical problems. Both MD Start and Exploramed focus on this principle. Anne Osdoit explained the approach of MD Start: "We rely and build on ideas that other people have. We typically don’t do the ideation part; instead, w...

Michael Ryan from Boston Scientific explained, "We consider ourselves a strategic investor. For us to invest in a company, three things need to be true: it needs to be an investment-grade asset with a great team and technology, it must be available at terms that provide the po...

At LSI Europe ‘23, a panel of executives from CMR Surgical explored the future of robotic surgery, discussing the challenges in the field and the innovative solutions CMR brings to the table. Through their VersiusⓇ system, CMR Surgical is working to transform the medtech lands...

Nicole J. Walker highlighted the evolution of investment trends with a DEI lens. Initially, the focus was on making treatments accessible for chronic conditions prevalent in diverse populations. Over time, this focus expanded to include culturally appropriate care, recognizing...

Engaging with strategic investors can provide significant benefits, although it often comes with added complexities. These investors can bring more than just capital—they offer expertise, market insights, and validation. https://www.lsieuropesummit.com/news/lessons-from-buildi...

The successful implementation of new technologies also depends on collaboration among all individuals who will be involved in the process. Williamson noted, "Having not only the doctor, the porter, and the nurse but also IT together at the same table allows them to discuss all...

At the core of medtech innovation is addressing real clinical problems. Both MD Start and Exploramed focus on this principle. Anne Osdoit explained the approach of MD Start: "We rely and build on ideas that other people have. We typically don’t do the ideation part; instead, w...

A significant focus of the medtech market is achieving the necessary revenue milestones to attract M&As. Most M&A activity in medtech occurs once companies have already demonstrated a viable market fit and revenue generation. https://www.lsieuropesummit.com/news/insigh...

Another critical point discussed was the need for thorough validation and localization of AI models. AI models trained in one region may not perform equally well in another due to differences in patient populations and care pathways. Viatgé highlighted this issue, saying, "You...

We Venture Capital, the corporate venture capital arm of Werfen, was recently launched to support innovation in diagnostics. Louise Warme, leading the initiative, shared insights about Werfen's growth and their new venture arm's objectives. She explained, "Werfen has been a fa...

Barcelona is rapidly emerging as a significant hub for medtech, digital health, and biotech innovation. Josep Sanfeliu, managing partner at Asabys, highlighted the region's robust infrastructure and research capabilities, underscoring its growth potential. "Barcelona is a good...

The medtech market is an ever-changing landscape shaped by innovations, investments, and challenges. Industry leaders gathered at the LSI Europe '23 medtech conference to share their perspectives on current trends and future directions. The panel included experts from Philips...

Digital transformation is a term that varies in definition depending on the organization and its current stage in technological adoption. At its core, it involves integrating digital tools to enhance operational efficiency and achieve strategic goals. "Digital transformation i...

Chronic disease management emerged as a crucial area where digital health can significantly contribute due to its substantial impact on healthcare costs. Joe Mullings emphasized, The sector I think we could have the most impact on is chronic disease management. I think that's...

Funding for neurotechnology poses unique challenges and offers substantial opportunities for medical device investors, compared to other fields like cardiovascular or ophthalmology. Ken Mariash emphasized, "This is one of the hottest areas in medtech, despite the downturn in f...

One of the most pressing needs in healthcare, according to Kothari, is the automation of administrative tasks. He explained that doctors spend significant time responding to emails and managing electronic health records (EHRs) – tasks that could be streamlined with AI. "The nu...

In a competitive commercial marketplace, what may set the Maestro system apart is its surgeon-centric design. Moon Surgical has crafted a system that is designed to complement the surgeon's laparoscopic expertise, rather than replace it. The novel interface and ergonomic desig...

InHeart, a pioneering medical device company, recently secured $11 million in fresh capital to accelerate the development and deployment of its innovative therapeutic and predictive cardiac solutions. The financing, led by Vesalius Biocapital IV and co-led by Elaia Partners, w...

Moon Surgical has announced that its Maestr System has received FDA clearance for commercial use. This milestone marks a significant leap forward in Moon’s ascent in robot-assisted laparoscopic surgery, promising to enhance the precision and efficiency of various surgical proc...